A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy

被引：5

作者：

Pang, S. H. ^{[1
]}

de Silva, K. ^{[2
]}

Napoli, J. ^{[1
]}

Jones, B. E. ^{[1
]}

机构：

[1] Royal N Shore Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW 2065, Australia

[2] Royal N Shore Hosp, Dept Anat Pathol, Sydney, NSW 2065, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2009年 / 39卷 / 07期

关键词：

hepatitis C; interferon; chronic liver disease; phlegmonous colitis; cirrhosis; PEGINTERFERON ALPHA-2A; LIVER-DISEASE; CIRRHOSIS;

D O I：

10.1111/j.1445-5994.2009.01919.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Phlegmonous colitis is an acute suppurative infection of the large bowel that is rarely described, rapidly fatal and often escapes clinical attention. Patients with chronic hepatic diseases appear to be predisposed to this condition. We report a novel case of fatal phlegmonous colitis in a cirrhotic patient receiving combination pegylated interferon and ribavirin for chronic hepatitis C, highlighting the importance of early recognition of this aggressive infectious entity.

引用

页码：481 / 484

页数：4

共 16 条

[1] Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis:: A retrospective study [J].

Bruno, Savino ;

Stroffolini, Tommaso ;

Colombo, Massimo ;

Bollani, Simona ;

Benvegnu, Luisa ;

Mazzella, Giuseppe ;

Ascione, Antonio ;

Santantonio, Teresa ;

Piccinino, Felice ;

Andreone, Pietro ;

Mangia, Alessandra ;

Gaeta, Giovanni B. ;

Persico, Marcello ;

Fagiuoli, Stefano ;

Almasio, Piero L. .

HEPATOLOGY, 2007, 45 (03) :579-587

[2] Vibrio vulnificus infection in patients with liver disease:: report of five autopsy cases [J].

Chen, YX ;

Satoh, T ;

Tokunaga, O .

VIRCHOWS ARCHIV, 2002, 441 (01) :88-92

[3]

GERARD PW, 1969, AM J CLIN PATHOL, V51, P338

[4] Bacterial translocation and its consequences in patients with cirrhosis [J].

Guarner, C ;

Soriano, G .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) :27-31

[5] Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis [J].

Heathcote, EJ ;

Shiffman, ML ;

Cooksley, WGE ;

Dusheiko, GM ;

Lee, SS ;

Balart, L ;

Reindollar, R ;

Reddy, RK ;

Wright, TL ;

Lin, A ;

Hoffman, J ;

De Pamphilis, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) :1673-1680

[6] Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study [J].

Iacobellis, Angelo ;

Siciliano, Massimo ;

Perri, Francesco ;

Annicchiarico, Brigida E. ;

Leandro, Gioacchino ;

Caruso, Nazario ;

Accadia, Laura ;

Bombardieri, Giuseppe ;

Andriulli, Angelo .

JOURNAL OF HEPATOLOGY, 2007, 46 (02) :206-212

[7]

Kakkar N, 1999, Indian J Pathol Microbiol, V42, P101

[8]

Kim Jeong Wook, 2004, Korean J Gastroenterol, V43, P104

[9]

Lucké B, 1944, AM J PATHOL, V20, P471

[10] LIVER-DISEASE, PHLEGMONOUS COLITIS, AND GRAM-NEGATIVE SEPSIS [J].

MENDELOFF, J ;

WENGER, J .

SOUTHERN MEDICAL JOURNAL, 1975, 68 (04) :507-510

← 1 2 →